No connection

Search Results

CBT

NEUTRAL
$76.85 Live
Cabot Corporation · NYSE
Target $77.8 (+1.2%)
$58.33 52W Range $83.71
Overview AI Snowflake Price Valuation Profitability Growth Health Statements Peers Insiders SEC Filings

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$4.01B
P/E
13.44
ROE
21.8%
Profit margin
8.6%
Debt/Equity
0.65
Dividend yield
2.34%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
Cabot Corporation presents a stable but stagnating profile, evidenced by a Piotroski F-Score of 4/9. While the company maintains strong profitability with an ROE of 21.82% and a consistent track record of earnings beats, it is currently facing significant headwinds with negative YoY revenue (-11.10%) and earnings growth (-18.20%). The stock is trading at a significant premium to both its Graham Number ($62.31) and Intrinsic Value ($40.04), suggesting limited upside potential at current price levels.

Key Strengths

Strong Return on Equity (ROE) of 21.82%
Consistent earnings beat track record (3 of last 4 quarters)
Sustainable dividend profile with a low payout ratio of 31.12%
Healthy liquidity with a current ratio of 1.67
Manageable leverage with a Debt/Equity ratio of 0.65

Key Risks

Negative YoY revenue growth (-11.10%) and earnings growth (-18.20%)
Trading significantly above defensive fair value (Graham Number $62.31)
Bearish technical trend (0/100 score)
Cyclical exposure to the Specialty Chemicals industry
Declining quarterly earnings progression in recent periods
AI Fair Value Estimate
Based on comprehensive analysis
$62.31
-18.9% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
55
Moderate
Value
35
Future
30
Past
80
Health
55
Dividend
75
AI Verdict
Stable but Overvalued
Key drivers: Strong ROE, Negative Growth, Valuation Premium
Confidence
90%
Value
35/100

Ref P/E 13.44, Graham Number $62.31, Intrinsic Value $40.04

Positives
  • Low Forward P/E of 11.20
Watchpoints
  • Price ($76.85) is 23% above Graham Number
  • Price is nearly double the growth-based intrinsic value
Future
30/100

Ref Revenue Growth -11.10%, Earnings Growth -18.20%

Positives
  • PEG ratio of 1.00 suggests fair pricing relative to growth
Watchpoints
  • Double-digit declines in both revenue and earnings growth
Past
80/100

Ref Quarterly Earnings Track Record

Positives
  • Exceptional history of beating analyst estimates over 25 quarters
  • Positive 5-year price change of 53.6%
Watchpoints
  • Recent 1-year return is flat (-0.9%)
Health
55/100

Ref Piotroski F-Score 4/9, Debt/Equity 0.65

Positives
  • Current ratio 1.67 indicates good short-term solvency
  • Debt/Equity 0.65 is below sector average
Watchpoints
  • Piotroski F-Score of 4/9 indicates only stable health, not strong
Dividend
75/100

Ref Yield 2.34%, Payout 31.12%

Positives
  • Low payout ratio (31.12%) provides high safety margin
  • Consistent dividend rate of $1.80
Watchpoints
  • Yield (2.34%) is modest

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$76.85
Analyst Target
$77.8
Upside/Downside
+1.2%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CBT and closest competitors.

Updated 2026-04-24
CBT
Cabot Corporation
Primary
5Y
+53.6%
3Y
+14.8%
1Y
-0.9%
6M
+9.1%
1M
+5.7%
1W
+3.2%
CC
The Chemours Company
Peer
5Y
+1.1%
3Y
+8.1%
1Y
+119.6%
6M
+91.7%
1M
+28.1%
1W
+14.8%
AAU
Allied Gold Corporation
Peer
5Y
+352.3%
3Y
+352.3%
1Y
+217.4%
6M
+81.2%
1M
-0.4%
1W
-0.7%
ARI
Aris Mining Corporation
Peer
5Y
+351.4%
3Y
+541.4%
1Y
+248.1%
6M
+90.1%
1M
+12.1%
1W
-7.7%
CGA
Centerra Gold Inc.
Peer
5Y
+134.1%
3Y
+188.7%
1Y
+184.3%
6M
+70.5%
1M
+12.0%
1W
-5.3%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
13.44
Forward P/E
11.2
PEG Ratio
1.0
P/B Ratio
2.55
P/S Ratio
1.11
EV/Revenue
1.4
EV/EBITDA
6.64
Market Cap
$4.01B

Profitability

Profit margins and return metrics

Profit Margin 8.62%
Operating Margin 15.19%
Gross Margin 25.56%
ROE 21.82%
ROA 10.22%

Growth

Revenue and earnings growth rates

Revenue Growth -11.1%
Earnings Growth -18.2%
Q/Q Revenue Growth -11.1%
Q/Q Earnings Growth -21.5%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.65
Moderate
Current Ratio
1.67
Good
Quick Ratio
0.97
Poor
Cash/Share
$4.4

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.8B
Gross Margin
24.9%
Op. Margin
15.2%
Net Margin
8.6%
Total Assets
$3.8B
Liabilities
$2.0B
Equity
$1.6B
Debt/Equity
1.29x
Operating CF
$0.1B
CapEx
$-0.1B
Free Cash Flow
$0.1B
FCF Yield
45%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-05
$N/A
2026-02-03
$1.53
+10.8% surprise
2025-11-03
$1.7
+1.4% surprise
2025-08-04
$1.9
+3.8% surprise

Basic Materials Sector Comparison

Comparing CBT against 109 companies in the Basic Materials sector (4 bullish, 41 neutral, 64 bearish)
P/E Ratio
13.44
This Stock
vs
37.99
Sector Avg
-64.6% (Discount)
Return on Equity (ROE)
21.82%
This Stock
vs
-10.47%
Sector Avg
-308.5% (Below Avg)
Profit Margin
8.62%
This Stock
vs
-7.78%
Sector Avg
-210.8% (Weaker)
Debt to Equity
0.65
This Stock
vs
1.02
Sector Avg
-36.0% (Less Debt)
Revenue Growth
-11.1%
This Stock
vs
38.21%
Sector Avg
-129.1% (Slower)
Current Ratio
1.67
This Stock
vs
5.92
Sector Avg
-71.9% (Weaker)

Similar Companies

Peer comparison within the same industry

CBT Cabot Corporation
NEUTRAL
Mkt Cap
$4.0B
P/E
13.4
ROE
21.8%
Price
$76.85
CC The Chemours Company
BEARISH
Mkt Cap
$4.0B
P/E
-
ROE
-93.8%
Price
$26.61
 Compare with CBT
AAUC Allied Gold Corporation
NEUTRAL
Mkt Cap
$3.9B
P/E
-
ROE
2.6%
Price
$31.14
 Compare with CBT
ARIS Aris Mining Corporation
NEUTRAL
Mkt Cap
$3.9B
P/E
45.8
ROE
6.3%
Price
$18.76
 Compare with CBT
CGAU Centerra Gold Inc.
NEUTRAL
Mkt Cap
$3.8B
P/E
6.7
ROE
31.4%
Price
$18.97
 Compare with CBT

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

WILSON FRANK ANDERS
Director
Stock Award
2026-01-08
2,298 shares
ARNOLD CYNTHIA A
Director
Stock Award
2026-01-08
2,298 shares
YAN CHRISTINE YINGLI
Director
Stock Award
2026-01-08
2,298 shares
VANLANCKER THIERRY F J
Director
Stock Award
2026-01-08
2,298 shares
MORROW MICHAEL M.
Director
Stock Award
2026-01-08
2,298 shares
ENRIQUEZ CABOT JUAN
Director
Stock Award
2026-01-08
486 shares
DEL GROSSO DOUGLAS G
Director
Stock Award
2026-01-08
2,298 shares
KIRBY WILLIAM C
Director
Stock Award
2026-01-08
486 shares
WILLIAMS MICHELLE ELIZABETH
Director
Stock Award
2026-01-08
2,298 shares
NATHOO RAFFIQ A
Director
Stock Award
2026-01-08
2,298 shares
NATHOO RAFFIQ A
Director
Option Exercise
2025-12-31
3,383 shares · $224,282
MASTERSON WILLIAM F III
Officer
Stock Award
2025-12-03
3,486 shares
KEOHANE SEAN D
Chief Executive Officer
Stock Award
2025-11-19
63,562 shares
MCLAUGHLIN ERICA
Chief Financial Officer
Stock Award
2025-11-19
15,226 shares
KALITA KAREN A
General Counsel
Stock Award
2025-11-19
8,602 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-03-17

Cabot Corporation filed an 8-K on March 17, 2026, likely to announce its quarterly financial results or a material corporate event.

10-Q
10-Q
2026-02-04

CBT filed its quarterly Form 10-Q on February 4, 2026. Specific financial highlights and risk factors were not provided in the available metadata.

8-K
8-K
2026-02-03

Cabot Corporation reported its fourth-quarter and full-year financial results for 2025.

DEF 14A
DEF 14A
2026-01-27

Cabot Corporation (CBT) filed a definitive proxy statement on January 27, 2026, providing shareholders with necessary information and voting materials for the upcoming annual meeting.

8-K
8-K
2026-01-14
10-K
10-K
2025-11-24

CBT filed its annual 10-K report on November 24, 2025. The provided excerpts do not contain specific financial metrics or detailed risk disclosures, limiting the available analysis of the company's current financial performance and risk profile.

8-K
8-K
2025-11-03

Cabot Corporation filed an 8-K on November 3, 2025, likely to announce its third quarter financial results.

10-Q
10-Q
2025-08-05

CBT filed its quarterly 10-Q report on August 5, 2025. Due to the absence of provided excerpts, specific financial highlights and risk factors are unavailable for analysis.

8-K
8-K
2025-08-04

Cabot Corporation (CBT) filed an 8-K on August 4, 2025, likely to report its second-quarter financial results.

8-K
8-K
2025-06-03

Cabot Corporation filed a current report on June 3, 2025, likely reporting the results of its annual meeting of shareholders.

10-Q
10-Q
2025-05-07
8-K
8-K
2025-05-06
8-K
8-K
2025-03-18
10-Q
10-Q
2025-02-06
8-K
8-K
2025-02-04
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
NONE
5 analysts
UBS
2026-02-05
Maintains
Neutral Neutral
Mizuho
2026-02-05
down
Outperform Neutral
UBS
2026-01-12
Maintains
Neutral Neutral
Mizuho
2025-12-18
Maintains
Outperform Outperform
JP Morgan
2025-11-28
Maintains
Underweight Underweight
Mizuho
2025-11-17
Maintains
Outperform Outperform
UBS
2025-11-05
Maintains
Neutral Neutral

Past News Coverage

Recent headlines mentioning CBT from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI Chat
Markets
Profile